《血液病理學(xué)雜志》向?qū)ρ翰±韺W(xué)感興趣的病理學(xué)家提供了進(jìn)行現(xiàn)代病理學(xué)評(píng)估淋巴組織和骨髓所需的所有信息。該雜志在病理學(xué)、分子生物學(xué)和造血系統(tǒng)疾病的臨床特征等領(lǐng)域發(fā)表評(píng)論、社論、評(píng)論、原始論文、指南和協(xié)議、輔助技術(shù)論文和病例報(bào)告。該雜志具有獨(dú)特的國(guó)際性，有助于解決疾病發(fā)病率的巨大地理差異。該雜志為所有對(duì)血液病理學(xué)感興趣的病理學(xué)家提供了可靠的參考點(diǎn)。參與分子診斷和淋巴瘤和白血病研究的分子生物學(xué)家也受益于該雜志。此外，該雜志對(duì)血液病學(xué)家處理淋巴瘤、白血病和其他疾病的患者非常感興趣。本期刊遵循雙盲審查程序。有關(guān)提交信息，請(qǐng)參閱作者說(shuō)明。

The Journal of Hematopathology provides pathologists interested in hematopathology with all the information needed to perform modern pathology in evaluating lymphoid tissues and bone marrow. The Journal publishes reviews, editorials, comments, original papers, guidelines and protocols, papers on ancillary techniques, and case reports in the fields of the pathology, molecular biology, and clinical features of diseases of the hematopoietic system.The Journal is unique in its international character, helping to address the huge geographical variations in incidence of disease.The Journal offers a sure reference point for all pathologists with an interest in hematopathology. Molecular biologists involved in the expanding field of molecular diagnostics and research on lymphomas and leukemia benefit from the journal, too. Furthermore, the journal is of major interest for hematologists dealing with patients suffering from lymphomas, leukemias, and other diseases.This journal follows a double-blind reviewing procedure. Please see the Instructions for Authors for submission information.